Humacyte Correlations
HUMA Stock | USD 3.13 0.12 3.99% |
The correlation of Humacyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Humacyte Correlation With Market
Weak diversification
The correlation between Humacyte and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Humacyte and DJI in the same portfolio, assuming nothing else is changed.
Humacyte |
Moving together with Humacyte Stock
0.65 | A | Agilent Technologies | PairCorr |
0.84 | ME | 23Andme Holding | PairCorr |
0.63 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
0.67 | DNLI | Denali Therapeutics | PairCorr |
0.78 | VCEL | Vericel Corp Ord | PairCorr |
0.79 | VCYT | Veracyte | PairCorr |
0.7 | VERA | Vera Therapeutics | PairCorr |
0.61 | DRTS | Alpha Tau Medical | PairCorr |
0.66 | SABSW | SAB Biotherapeutics | PairCorr |
0.68 | VINC | Vincerx Pharma | PairCorr |
0.66 | VRAX | Virax Biolabs Group | PairCorr |
0.8 | VRDN | Viridian Therapeutics Downward Rally | PairCorr |
0.85 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.73 | VTRS | Viatris | PairCorr |
0.68 | VTYX | Ventyx Biosciences | PairCorr |
Moving against Humacyte Stock
0.74 | DVAX | Dynavax Technologies | PairCorr |
0.67 | VALN | Valneva SE ADR | PairCorr |
0.45 | VIGL | Vigil Neuroscience | PairCorr |
0.36 | DTIL | Precision BioSciences Earnings Call This Week | PairCorr |
0.32 | EQ | Equillium | PairCorr |
0.79 | VRTX | Vertex Pharmaceuticals | PairCorr |
0.63 | VRNA | Verona Pharma PLC | PairCorr |
0.6 | EDSA | Edesa Biotech | PairCorr |
0.51 | VTVT | vTv Therapeutics Trending | PairCorr |
0.44 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.43 | VSTM | Verastem | PairCorr |
0.43 | EDIT | Editas Medicine | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Humacyte Stock performing well and Humacyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Humacyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CRNX | 2.71 | (0.59) | 0.00 | (0.84) | 0.00 | 3.78 | 21.52 | |||
VRDN | 2.90 | (0.16) | 0.00 | (0.29) | 0.00 | 4.61 | 29.75 | |||
CYTK | 2.15 | (0.11) | 0.00 | (0.48) | 0.00 | 4.56 | 17.67 | |||
GPCR | 3.60 | (0.44) | 0.00 | (0.35) | 0.00 | 5.95 | 25.66 | |||
ICVX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
IMCR | 2.02 | (0.02) | 0.00 | (0.13) | 0.00 | 4.79 | 10.64 | |||
MIRM | 1.78 | 0.17 | 0.08 | 0.08 | 2.13 | 4.13 | 13.96 | |||
LRMR | 3.64 | (1.13) | 0.00 | (0.58) | 0.00 | 5.82 | 22.70 | |||
KALV | 2.64 | 0.61 | 0.18 | 0.35 | 2.90 | 5.75 | 15.24 | |||
LYRA | 2.90 | (0.21) | 0.00 | (0.83) | 0.00 | 5.56 | 25.31 |
Humacyte Corporate Management
Harold Alterson | Senior Quality | Profile | |
Sabrina Osborne | Executive People | Profile | |
Dale Sander | Chief CFO | Profile | |
William Scheessele | Chief Officer | Profile | |
Yang MD | Chief Officer | Profile | |
Shamik MD | Chief Officer | Profile |